Effects of Deep Breathing Exercises Two Months After Cardiac Surgery
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Hypothesis: Deep breathing exercises performed during the first two months after cardiac surgery, will improve pulmonary function and patient-perceived quality of recovery.
Specific aim: To evaluate the effectiveness of breathing exercises performed with a mechanical device for positive expiratory pressure during the first two months after cardiac surgery compared to a control group performing no breathing exercises.
Design: A prospective, randomized, controlled two-center study.
| Condition | Intervention | Phase |
|---|---|---|
|
CABG Valve Surgery |
Other: Breathing exercises |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Effects of Deep Breathing Exercises Two Months After Cardiac Surgery |
- Lung function measured as Forced expiratory volume in 1 second (FEV1) [ Time Frame: Two months after surgery ] [ Designated as safety issue: Yes ]Spirometry is performed preoperatively and 2 months after surgery at the Departments of Clinical Physiology. A Jaeger MasterScreen Pulmonary functiontest (PFT)/Bodybox will be used at the University hospitals in Uppsala and Örebro. The medical laboratory technologists are blinded to the patient's treatment allocation. Static and dynamic lung volumes will be measured.
- Postoperative quality of recovery [ Time Frame: Two months postoperatively ] [ Designated as safety issue: Yes ]Physical activity, postoperative pain, day of discharge, signs of pneumonia or pulmonary comlications will be noted. Patient-perceived quality of recovery will be assessed using a translated version of a recently validated quality of recovery score (QoR-40) designed to measure the patient`s health status after surgery and anaesthesia. The SF (short form) -36 (first version) will be used for assessment of quality of life aspects.
| Estimated Enrollment: | 360 |
| Study Start Date: | September 2007 |
| Estimated Study Completion Date: | August 2012 |
| Estimated Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Breathing exercises
On the fourth postoperative day the patients are randomly assigned to a Treatment group continuing to perform deep breathing exercises for 2 months postoperatively and to a Control group who will perform no breathing exercises after the third postoperative day. Patient management is otherwise similar in the groups. The patients in the Deep breathing group will be instructed to perform breathing exercises (3 x 10 deep breaths) 5 times a day (document compliance) during the two postoperative months.
|
Other: Breathing exercises
On the fourth postoperative day the patients are randomly assigned to a Treatment group continuing to perform deep breathing exercises for 2 months postoperatively and to a Control group who will perform no breathing exercises after the third postoperative day. Patient management is otherwise similar in the groups. The patients in the Deep breathing group will be instructed to perform breathing exercises (3 x 10 deep breaths) 5 times a day (document compliance) during the two postoperative months. A Positive expiratory pressure (PEP) device PEP ventil, System 22 (Rium Medical, Täby, Sweden) is used to create an expiratory resistance of +10 cm H2O.
Other Names:
|
|
No Intervention: Control group
No breathing exercises.
|
Other: Breathing exercises
On the fourth postoperative day the patients are randomly assigned to a Treatment group continuing to perform deep breathing exercises for 2 months postoperatively and to a Control group who will perform no breathing exercises after the third postoperative day. Patient management is otherwise similar in the groups. The patients in the Deep breathing group will be instructed to perform breathing exercises (3 x 10 deep breaths) 5 times a day (document compliance) during the two postoperative months. A Positive expiratory pressure (PEP) device PEP ventil, System 22 (Rium Medical, Täby, Sweden) is used to create an expiratory resistance of +10 cm H2O.
Other Names:
|
Detailed Description:
Contribution: The study will be taken place at two University hospitals in Sweden.
Uppsala university hospital (PhD, Registered physical therapist (RPT)) Margareta Emtner and RPT Charlotte Urell) and Örebro university hospital; (Elisabeth Westerdahl and RPT Marcus Jonsson).
Time planning: Application to the Research Ethics Committee april 2007. Data collection 2007-2011. Statistical analysis and manuscript writing 2011.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- A sample of 360 adults (>18 years) patients undergoing cardiac surgery at the two University hospitals are invited to participate in the study.
- Type of cardiac surgery included will be Coronary artery bypass graft surgery (CABG) with saphenous vein grafts and/or internal mammary artery graft, valve surgery or combinations of CABG and valve surgery.
Exclusion Criteria:
- Patients who have an emergency operation, previous cardiac or lung surgery, renal dysfunction requiring dialysis or are unable to communicate in Swedish will not be included.
- Patients who requires more than 24 hours respirator treatment, reintubation, reoperation, sternum instability/infection or develop a neurological, mental or haemodynamic complication that affects the patients' ability to collaborate, will be excluded.
Contacts and Locations| Contact: Elisabeth A Westerdahl, PhD, RPT | +46 19 6025847 | elisabeth.westerdahl@orebroll.se |
| Sweden | |
| Uppsala University | Recruiting |
| Uppsala, Sweden, 751 85 | |
| Contact: Charlotte Urell, PhD student 018-471 47 79 charlotte.urell@neuro.uu.se | |
| Örebro University Hospital | Recruiting |
| Örebro, Sweden, 701 85 | |
| Contact: Elisabeth Westerdahl, PhD, RPT +46 19 6025847 elisabeth.westerdahl@orebroll.se | |
| Principal Investigator: Elisabeth Westerdahl, PhD, RPT | |
| Principal Investigator: | Elisabeth Westerdahl, PhD, RPT | University Hospital Orebro |
More Information
Publications:
| Responsible Party: | Elisabeth Westerdahl, PhD, RPT, Uppsala University |
| ClinicalTrials.gov Identifier: | NCT01282671 History of Changes |
| Other Study ID Numbers: | Multic-PEP 2007-160 |
| Study First Received: | December 6, 2010 |
| Last Updated: | June 27, 2012 |
| Health Authority: | Sweden: Regional Ethical Review Board |
Keywords provided by Uppsala University:
|
breathing exercises cardiac surgery lung function postoperative complication positive expiratory pressure |
Additional relevant MeSH terms:
|
Respiratory Aspiration Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on June 18, 2013